Log in to save to my catalogue

Bezlotoxumab during the first episode of Clostridioides difficile infection in patients at high risk...

Bezlotoxumab during the first episode of Clostridioides difficile infection in patients at high risk...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2916407556

Bezlotoxumab during the first episode of Clostridioides difficile infection in patients at high risk of recurrence

About this item

Full title

Bezlotoxumab during the first episode of Clostridioides difficile infection in patients at high risk of recurrence

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

European journal of clinical microbiology & infectious diseases, 2024-03, Vol.43 (3), p.533-540

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

Purpose
To describe a cohort with a high risk of recurrence who received bezlotoxumab during the first episode of
Clostridioides difficile
infection (CDI) and to compare this cohort with patients with similar characteristics who did not receive the monoclonal antibody.
Methods
A prospective and multicentre study of patients with a hi...

Alternative Titles

Full title

Bezlotoxumab during the first episode of Clostridioides difficile infection in patients at high risk of recurrence

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2916407556

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2916407556

Other Identifiers

ISSN

0934-9723

E-ISSN

1435-4373

DOI

10.1007/s10096-024-04762-6

How to access this item